Author page: Kathrin Folkendt

Noom Adds AI Body Scan Feature to Monitor Body Composition Changes During Weight Loss

Digital healthcare company Noom has introduced a new body scan feature that enables users to track body composition changes using their smartphone camera, addressing growing attention to muscle mass retention during weight loss treatments. The new feature, developed in partnership with Prism Labs, allows users to conduct body composition analysis through a 10-second video recording in the Noom app. The AI-powered system…

Persperity Health Raises $1M to Develop Sweat-Based Hormone Monitoring Technology

Persperity Health, a Caltech spin-out, has secured $1 million in pre-seed funding to develop sweat-sensing technology for non-invasive hormone monitoring. The round was led by Freeflow Ventures, with participation from Caltech, Wilson Hill Ventures, Heritage Group, and ATMA Capital. The company’s technology, exclusively licensed from Caltech and developed by Dr. Wei Gao and Dr. Cui Ye, enables real-time hormone monitoring through sweat…

American Heart Association Launches $75M Fund to Transform Women’s Heart and Brain Health

The American Heart Association (AHA) is expanding its venture capital initiatives with a new $75 million fund focused specifically on women’s cardiovascular and brain health innovation. The Go Red For Women Fund, which has already secured $55 million in commitments, aims to address critical gaps in healthcare that disproportionately affect women. “There’s a significant disparity in healthcare venture funding,” explains Lisa Suennen,…

Oura Expands Women’s Health Features with Fertile Window Tracking

Oura has announced the addition of Fertile Window to its Cycle Insights feature, expanding its women’s health tracking capabilities. The new feature, currently rolling out to iOS users with Android following in coming weeks, uses physiological data to estimate users’ most fertile days. The feature leverages Oura’s existing temperature tracking capabilities, along with other biomarkers including heart rate, heart rate variability, and…

‘RedWave’ Satirical Period Tracker Takes Aim at Reproductive Rights Debates

A fictional period tracking app called “RedWave” has emerged as part of a creative campaign to highlight reproductive rights concerns ahead of the 2024 election. The initiative comes from Creatives for Harris, a group of creative professionals organizing with their skills and time to support the Harris-Walz ticket in 2024. The satirical campaign presents the app as one “designed by men, for…

ARPA-H Announces $110M in Women’s Health Research Grants

The Advanced Research Projects Agency for Health (ARPA-H) has announced its first Sprint for Women’s Health awardees, investing $110 million across 23 projects focused on women’s healthcare. The initiative, which drew more than 1,700 submissions from over 30 countries, targets critical areas including brain health, reproductive health, and cardiovascular disease. “It’s been less than 10 months since we first launched the Sprint…

Celmatix Achieves Milestone in Development of Oral Fertility Drug

In what could mark a significant shift in fertility treatment, Celmatix has announced the nomination of its first lead compound in its oral Follicle Stimulating Hormone receptor (FSHR) agonist drug development program. The breakthrough, announced during the American Society for Reproductive Medicine (ASRM) annual meeting in Denver, could potentially transform fertility treatments by replacing traditional hormone injections with oral medications. The development…

DeepHealth Strengthens AI Breast Cancer Screening Position with Kheiron Acquisition

DeepHealth has announced its acquisition of UK-based Kheiron Medical Technologies, marking a significant consolidation in the AI-powered breast cancer screening space. The acquisition brings together DeepHealth’s Smart Mammo platform with Kheiron’s Mia (Mammography Intelligent Assessment) suite of solutions. The move appears strategically timed as AI continues to gain traction in medical imaging, particularly in mammography where radiologist shortages and increasing screening volumes…